| A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis RL Greenman, RMH Schein, MA Martin, RP Wenzel, NR Maclntyre, ... Jama 266 (8), 1097-1102, 1991 | 952 | 1991 |
| A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis … JL Vincent, MK Ramesh, D Ernest, SP LaRosa, J Pachl, N Aikawa, ... Critical care medicine 41 (9), 2069-2079, 2013 | 334 | 2013 |
| Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial JL Vincent, B Francois, I Zabolotskikh, MK Daga, JB Lascarrou, MY Kirov, ... Jama 321 (20), 1993-2002, 2019 | 272 | 2019 |
| Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial S Vermeire, WJ Sandborn, S Danese, X Hébuterne, BA Salzberg, ... The Lancet 390 (10090), 135-144, 2017 | 189 | 2017 |
| Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial MA Petri, RG Lahita, RF Van Vollenhoven, JT Merrill, M Schiff, EM Ginzler, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 189 | 2002 |
| Results of a second double-blind, randomized, controlled trial of antiendotoxin antibody E5 in gram-negative sepsis R Wenzel, R Bone, A Fein, R Quenzer, J Schentag, KJ Gorelick, N Wedel, ... Program and abstracts of the 31st Interscience Conference on Antimicrobial …, 1991 | 113 | 1991 |
| Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study WJ Sandborn, SD Lee, D Tarabar, E Louis, M Klopocka, J Klaus, ... Gut 67 (10), 1824-1835, 2018 | 110 | 2018 |
| Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex JO Kahn, KJ Gorelick, G Gatti, CJ Arri, JD Lifson, JG Gambertoglio, ... Antimicrobial agents and chemotherapy 38 (2), 260-267, 1994 | 87 | 1994 |
| The HA-1A monoclonal antibody for gram-negative sepsis GA Schmidt The New England journal of medicine 325 (4), 279-283, 1991 | 61 | 1991 |
| Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis RN GREENBERG, KM WILSON, AY KUNZ, NI WEDEL, KJ GORELICK Critical care medicine 20 (6), 730-735, 1992 | 53 | 1992 |
| Production and clinical development of a Hansenula polymorpha-derived PEGylated hirudin GC Avgerinos, BG Turner, KJ Gorelick, A Papendieck, U Weydemann, ... Seminars in thrombosis and hemostasis 27 (04), 357-372, 2001 | 47 | 2001 |
| Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome DC Dale, F Firkin, AA Bolyard, M Kelley, V Makaryan, KJ Gorelick, ... Blood, The Journal of the American Society of Hematology 136 (26), 2994-3003, 2020 | 46 | 2020 |
| Results of the GL701 (DHEA) multicenter steroid-sparing SLE study. M Petri, R Lahita, J McGuire, R vanVollenhoven, V Strand, A Kunz, ... Arthritis and Rheumatism 40 (9), 1769-1769, 1997 | 31 | 1997 |
| Randomized placebo-controlled study of E5 monoclonal antiendotoxin antibody K Gorelick, PJ Scannon, J Hannigan, N Wedel, SK Ackerman Therapeutic monoclonal antibodies, 253-261, 1990 | 30 | 1990 |
| Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab [SHP647] for the treatment of ulcerative colitis: the open-label study TURANDOT II W Reinisch, WJ Sandborn, S Danese, X Hébuterne, M Kłopocka, ... Journal of Crohn's and Colitis 15 (6), 938-949, 2021 | 29 | 2021 |
| Effect of PF-00547659 on central nervous system immune surveillance and circulating β7+ T cells in Crohn’s disease: report of the TOSCA study G D’Haens, S Vermeire, H Vogelsang, M Allez, P Desreumaux, ... Journal of Crohn's and Colitis 12 (2), 188-196, 2018 | 28 | 2018 |
| Efficacy results of a randomized multicenter trial of E5 antiendotoxin monoclonal antibody in patients with suspected gram-negative sepsis K Gorelick, R Jacobs, H Chmel, G Trenholme, R Greenman Proceedings of the 29th International Conference on Antimicrobial Agents and …, 1989 | 26 | 1989 |
| TURANDOT: a randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to … S Vermeire, W Sandborn, S Danese, X Hebuterne, B Salzberg, ... Journal Of Crohns & Colitis 9, S13-S14, 2015 | 25 | 2015 |
| A randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of anti-MAdCAM antibody PF-00547659 (PF) in patients with moderate to severe … W Reinisch, W Sandborn, S Danese, F Cataldi, X Hebuterne, B Salzberg, ... Gastroenterology 148 (4), S1193-S1193, 2015 | 22 | 2015 |
| 825 Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease: Results of the OPERA study W Sandborn, SD Lee, D Tarabar, E Louis, M Klopocka, J Klaus, ... Gastroenterology 148 (4), S-162, 2015 | 21 | 2015 |
